Rabbit CYP4B1 engineered for high-level expression in Escherichia coli:: ligand stabilization and processing of the N-terminus and heme prosthetic group

被引:41
作者
Cheesman, MJ
Baer, BR
Zheng, YM
Gillam, EMJ
Rettie, AE [1 ]
机构
[1] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA
[2] Univ Queensland, Sch Biomed Sci, Dept Physiol & Pharmacol, St Lucia, Qld 4072, Australia
关键词
cytochrome P450; CYP4B1; E coli expression; N-terminal modifications; post-translational processing; laurate hydroxylase; heme-binding; covalent modification;
D O I
10.1016/S0003-9861(03)00278-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Modifications at the N-terminus of the rabbit CYP4B1 gene resulted in expression levels in Escherichia coli of up to 660 nmol/L. Solubilization of the enzyme from bacterial membranes led to substantial conversion to cytochrome P420 unless alpha-naphthoflavone was added as a stabilizing ligand. Mass spectrometry analysis and Edman sequencing of purified enzyme preparations revealed differential N-terminal post-translational processing of the various constructs expressed. Notably, bacterial expression of CYP4B1 produced a holoenzyme with >98.5% of its heme prosthetic group covalently linked to the protein backbone. The near fully covalently linked hernoproteins exhibited similar rates and regioselectivities of lauric acid hydroxylation to that observed previously for the partially heme processed enzyme expressed in insect cells. These studies shed new light on the consequences of covalent heme processing in CYP4B1 and provide a facile system for future mechanistic and structural studies with the enzyme. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:17 / 24
页数:8
相关论文
共 40 条
[1]   EXPRESSION AND ENZYMATIC-ACTIVITY OF RECOMBINANT CYTOCHROME-P450 17-ALPHA-HYDROXYLASE IN ESCHERICHIA-COLI [J].
BARNES, HJ ;
ARLOTTO, MP ;
WATERMAN, MR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (13) :5597-5601
[2]   MAXIMAL EXPONENTIAL-GROWTH RATE AND YIELD OF ESCHERICHIA-COLI OBTAINABLE IN A BENCH-SCALE FERMENTOR [J].
BAUER, S ;
SHILOACH, J .
BIOTECHNOLOGY AND BIOENGINEERING, 1974, 16 (07) :933-941
[3]   Characterization of pulmonary CYP4B2, specific catalyst of methyl oxidation of 3-methylindole [J].
Carr, BA ;
Ramakanth, S ;
Dannan, GA ;
Yost, GS .
MOLECULAR PHARMACOLOGY, 2003, 63 (05) :1137-1147
[4]  
CZERWINSKI M, 1991, CANCER RES, V51, P4636
[5]   Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans [J].
Dickmann, LJ ;
Rettie, AE ;
Kneller, MB ;
Kim, RB ;
Wood, AJJ ;
Stein, CM ;
Wilkinson, GR ;
Schwarz, UI .
MOLECULAR PHARMACOLOGY, 2001, 60 (02) :382-387
[6]   N-terminal deletions and His-tag fusions dramatically affect expression of cytochrome P4502C2 in bacteria [J].
Doray, B ;
Chen, CD ;
Kemper, B .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 393 (01) :143-153
[7]   HIGH-LEVEL EXPRESSION OF FUNCTIONAL HUMAN CYTOCHROME-P450 1A2 IN ESCHERICHIA-COLI [J].
FISHER, CW ;
CAUDLE, DL ;
MARTINWIXTROM, C ;
QUATTROCHI, LC ;
TUKEY, RH ;
WATERMAN, MR ;
ESTABROOK, RW .
FASEB JOURNAL, 1992, 6 (02) :759-764
[8]   Positional specificity of rabbit CYP4B1 for ω-hydroxylation of short-medium chain fatty acids and hydrocarbons [J].
Fisher, MB ;
Zheng, YM ;
Rettie, AE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (02) :352-355
[9]  
GASSER R, 1989, MOL PHARMACOL, V35, P617
[10]   Human cytochrome P450 enzymes expressed in bacteria: Reagents to probe molecular interactions in toxicology [J].
Gillam, EMJ .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 (11) :877-886